Effect of aggregated immunoglobulin A1 from immunoglobulin A nephropathy patients on nephrin expression in podocytes

Nephrology

Volumn 14, Issue 2, 2009, Pages 213-218

  Wang, Cheng ^a   Ye, Zengchun ^a   Peng, Hui ^a   Tang, Hua ^a   Liu, Xun ^a   Chen, Zhujiang ^a   Yu, Xueqing ^a   Lou, Tanqi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Immunoglobulin A nephropathy; Immunoglobulin A1; Nephrin; Podocyte

Indexed keywords

IMMUNOGLOBULIN A1; JACALIN; MESSENGER RNA; NEPHRIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN AGGREGATE; MESANGIUM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CULTURE MEDIA; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MEMBRANE PROTEINS; MICE; PODOCYTES; RNA, MESSENGER;

EID: 63849133205     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01025.x     Document Type: Article

References (28)

1. Li LS, Liu Zh. Epidemiologic data of renal diseases from a single unit in china: Analysis based 13,159 renal biopsies. Kidney Int. 2004 66 : 920 3.
2. Giannakakis K, Feriozzi S, Perez M et al. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy. J. Am. Soc. Nephrol. 2007 18 : 3139 46.
3. van der Boog PJ, van Kooten C, de Fijter JW et al. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005 67 : 813 8214.
4. Xu LX, Zhao MH. Aberrantly glycosylated IgA1 are closed associated with pathologic phenotype of IgA nephropathy. Kidney Int. 2005 167 72.
5. Ding JX, Xu LX, Lv JC et al. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Clin. Immunol. 2007 125 : 268 74.
6. Peng AI, Gu Y, Xiao T et al. Clinicopathological characteristics of IgA nephropathy with urinary podocyte excretion. Chin. J. Nephrol. 2007 23 : 283 5.
7. Lemley KV, Lafayette RA, Safai M et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002 61 : 1475 85.
8. Tomino Y. Pathogenesis of IgA nephropathy. Contrib. Nephrol. 2007 157 : 1 7.
9. Luimula P, Ahola H, Wanf SX et al. Nephrin in experimental glomerular disease. Kidney Int. 2000 58 : 1461 8.
10. Doublier S, Ruostalainen V, Salvidlo G et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephritic syndrome. Am. J. Pathol. 2001 158 : 1723 31.
11. Wang CH, Peng H, Tang H et al. Serum IgA1 from IgA nephropathy induces apoptosis in podocytes through direct and indirect pathway. Clin. Invest. Med. 2007 30 : E240 9.
12. Wang Y, Zhao MH, Zhang YK et al. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin. Exp. Immunol. 2004 136 : 168 75.
13. Wang Y, Zhao MH, Zhang Y et al. Serum IgA(1) from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells. Zhonghua Yi Xue Za Zhi 2002 82 : 1406 9.
14. To WY, Leung JC, Lai KN et al. Identification and characterization of human serum alpha2-HS glycoprotein as a jacalin-bound protein. Biochim. Biophys. Acta. 1995 1249 : 58 64.
15. Mundel P, Reuser J, Zúñiga Mejía Borja A et al. Rearrangement of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 1997 236 : 248.
16. Chadban SJ, Tesch GH, Foti R et al. Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo. Immunology 1998 94 : 72 8.
17. Oortwijn BD, Roos A, Royle L et al. Differential glycosylation of polymeric and monomeric IgA: A possible role in glomerular inflammation in IgA nephropathy. J. Am. Soc. Nephrol. 2006 16 : 2127 37.
18. Jia J, Ding G, Zhu J et al. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am. J. Nephrol. 2008 28 : 500 7.
19. Benigni A, Tomasoni S, Gagliardini E et al. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J. Am. Soc. Nephrol. 2001 12 : 941 8.
20. Macconi D, Bonomelli M, Benigni A et al. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am. J. Pathol. 2006 168 : 42 54.
21. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J. Clin. Invest. 2001 108 : 807 16.
22. Ichikawa I, Ma J, Motojima M et al. Podocyte damage damages podocytes: Autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr. Opin. Nephrol. Hypertens. 2005 14 : 205 10.
23. Michaud JL, Kennedy CR. The podocyte in health and disease: Insights from the mouse. Clin. Sci. 2007 112 : 325 235.
24. Kestila M, Lenkkeri U, Mannikko M et al. Positionally cloned gene for a novel glomerualr protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1998 1 : 575 82.
25. Partrakka J, Kestila M, Wartiovaara J et al. Congential nephrotic syndrome: Features resulting from different mutations in Finnish patients. Kidney Int. 2000 58 : 971 80.
26. Shih NY, Li J, Karpitskii V et al. Congenital nephrotic syndrome in mice lacking CD2- associated protein. Science 1999 286 : 312 5.
27. Rebecca R, Moin A, Peter W et al. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am. J. Physiol. Renal Physiol. 2005 288 : F48 57.
28. Gagliardini E, Benigni A, Tomasoni S et al. Targeted downregulation of extracellular nephin in human IgA nephropathy. Am. J. Nephrol. 2003 23 : 277 86.